Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Clinical trial NCT04393220 · COMPLETED

Trial details

NCT number: NCT04393220
Sponsor: Fuda Cancer Hospital, Guangzhou
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progress Free Survival (PFS) and Overall Survival (OS)

Start date: 2020-05-11
Primary completion: 2021-07-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.